Alto Neuroscience (ANRO) Non Operating Income (2023 - 2026)

Alto Neuroscience has reported Non Operating Income for 4 years, with the latest figure at $901000.0 in Q1 2026.

• Quarterly Non Operating Income rose 77.71% year-over-year to $901000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.5 million (down 47.6% YoY) and the FY2025 annual result came in at $3.1 million, down 56.46% from the prior year.
• Non Operating Income rose to $901000.0 in Q1 2026 per ANRO's latest filing, from $873000.0 in the prior quarter.
• Over five years, Non Operating Income peaked at $2.3 million in Q2 2024 and troughed at -$83000.0 in Q1 2023.
• A 4-year average of $977692.3 and a median of $873000.0 in 2025 frame the typical range for Non Operating Income.
• The sharpest annual moves came in 2024 and 2025: Non Operating Income surged 1267.47% in 2024, then sank 63.39% in 2025.
• Over 4 years, Non Operating Income stood at $548000.0 in 2023, then jumped by 227.74% to $1.8 million in 2024, then plunged by 51.39% to $873000.0 in 2025, then climbed by 3.21% to $901000.0 in 2026.
• According to Business Quant data, Non Operating Income over the past three periods registered $901000.0, $873000.0, and $770000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.